Printer Friendly
The Free Library
14,538,038 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

University of California obtains United States patent.


University of California The University of California has a combined student body of more than 191,000 students, over 1,340,000 living alumni, and a combined systemwide and campus endowment of just over $7.3 billion (8th largest in the United States).  (Oakland, CA) has patented a method for mediating the biological effects of the cytokine Cytokine

Any of a group of soluble proteins that are released by a cell to send messages which are delivered to the same cell (autocrine), an adjacent cell (paracrine), or a distant cell (endocrine).
 TNF TNF
abbr.
tumor necrosis factor


TNF,
n an abbreviation for tumor
necrosis
f
 by binding to receptors on the surface of cells. The patent describes new proteins and polynucleotides that promote enzymatic cleavage and release of TNF receptors. Also provided are methods for identifying additional compounds that influence TNF receptor shedding. As the active ingredient An active ingredient, also active pharmaceutical ingredient (or API), is the substance in a drug that is pharmaceutically active. Some medications may contain more than one active ingredient.  in a pharmaceutical composition, the products of this invention increase or decrease TNF signal transduction, thereby alleviating the pathology of disease. (US 6,930,084)
COPYRIGHT 2005 Biotech Patent News
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:method for mediating the biological effects of the cytokine TNF
Publication:BIOTECH Patent News
Article Type:Brief Article
Geographic Code:1USA
Date:Jul 1, 2005
Words:85
Previous Article:University of Missouri obtains United States patent.(Brief Article)
Next Article:Bristol-Myers Squibb obtains United States patent.(novel Gluconobacter oxydans 2-ketoreductase )(Brief Article)
Topics:



Related Articles
UCB INITIATES ADDITIONAL SHORT-TERM CLINICAL STUDY OF CIMZIA.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles